SG Americas Securities’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-251,982
| Closed | -$1.01M | – | 3800 |
|
|
2019
Q4 | $1.01M | Buy |
+251,982
| New | +$1.18M | 0.01% | 1251 |
|
|
2019
Q2 | – | Sell |
-20,385
| Closed | -$118K | – | 3619 |
|
|
2019
Q1 | $118K | Buy |
+20,385
| New | +$210K | ﹤0.01% | 2950 |
|
|
2018
Q3 | – | Sell |
-12,820
| Closed | -$328K | – | 3611 |
|
|
2018
Q2 | $328K | Buy |
12,820
+7,640
| +147% | +$178K | ﹤0.01% | 2303 |
|
|
2018
Q1 | $104K | Buy |
+5,180
| New | +$121K | ﹤0.01% | 2941 |
|
|
2017
Q4 | – | Sell |
-9,213
| Closed | -$191K | – | 3837 |
|
|
2017
Q3 | $191K | Buy |
+9,213
| New | +$156K | ﹤0.01% | 2619 |
|
|
2017
Q1 | – | Sell |
-9,241
| Closed | -$116K | – | 3682 |
|
|
2016
Q4 | $116K | Buy |
9,241
+1,031
| +13% | +$19.2K | ﹤0.01% | 2768 |
|
|
2016
Q3 | $230K | Buy |
+8,210
| New | +$275K | ﹤0.01% | 2377 |
|
|
2016
Q1 | – | Sell |
-4,165
| Closed | -$143K | – | 3354 |
|
|
2015
Q4 | $143K | Sell |
4,165
-7,725
| -65% | -$241K | ﹤0.01% | 2260 |
|
|
2015
Q3 | $342K | Buy |
11,890
+3,920
| +49% | +$168K | ﹤0.01% | 1191 |
|
|
2015
Q2 | $357K | Buy |
7,970
+4,733
| +146% | +$178K | ﹤0.01% | 1666 |
|
|
2015
Q1 | $112K | Buy |
+3,237
| New | +$88.1K | ﹤0.01% | 2213 |
|
Other funds holding DPLO
SG Americas Securities's DPLO Position: Q1 2020 in Review
SG Americas Securities sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 251,982 shares — an estimated $1.01M sold.
SG Americas Securities first reported a position in DPLO in Q1 2015 and held it in 11 quarters. The position peaked at $1.01M in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- SG Americas Securities reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- SG Americas Securities sold 251,982 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.01M.
- SG Americas Securities first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 11 quarters.
- SG Americas Securities's DIPLOMAT PHARMACY, INC. position peaked at $1.01M in Q4 2019.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on SG Americas Securities's 13F filing for Q1 2020, filed 30 Apr 2020.